LONDON (AFX) - SR Pharma ticked up 2 pence to 33-1/2 after the company ann
ounced the successful completion of Toxicology Studies for its systemically delivered RNAi product candidate Atu027.
And Torex Retail put on 3-3/4 to 51 as the supplier of IT solutions to retail, hospitality and quick service restaurants worldwide revealed that senior management has invested 500,000 stg (1.06 mln shares at 47 pence apiece) in the company.
Meanwhile, in the short term, the board confirms that the group is performing in line with underlying trading forecasts ahead of the year-end close at the end of December.
Elsewhere, Coal International moved ahead 2-1/2 to 54-1/2 following the increase of the existing loan facility agreement with Cambrian Mining to 13.5 mln stg from 8.2 million.
COPYRIGHT Copyright AFX News Limited 2006. All rights reserved. The copying, republication or redistribution of AFX News Content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News. AFX News and AFX Financial News Logo are registered trademarks of AFX News Limited
Datafeed and UK data supplied by NETbuilder and Interactive Data.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.